We are live on ! Find out more
AC

Antara Capital Portfolio holdings

AUM $30.2K
1-Year Est. Return 5.24%
This Fund
S&P 500
This Quarter Est. Return
-0.64%
1 Year Est. Return
-5.24%
3 Year Est. Return
-39.78%
5 Year Est. Return
-45.29%
10 Year Est. Return
AUM
$2.02B
AUM Growth
+$717M
Cap. Flow
+$521M
Cap. Flow %
25.73%
Top 10 Hldgs %
43.62%
Holding
297
New
118
Increased
24
Reduced
8
Closed
65

Sector Composition

Rank Sector Weight
1 Financials 9.53%
2 Industrials 7.61%
3 Consumer Discretionary 5.72%
4 Real Estate 3.59%
5 Communication Services 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPAR
101
DELISTED
Catalyst Partners Acquisition Corp. Class A Ordinary Share
CPAR
$2.92M 0.14%
300,000
BTNB
102
DELISTED
Bridgetown 2 Holdings Limited Class A Ordinary Shares
BTNB
$2.73M 0.13%
275,572
+100,572
+57% +$1M
ZGN icon
103
Zegna
ZGN
$4.02B
$2.62M 0.13%
+250,000
New +$2.85M
BBIO icon
104
CALL
BridgeBio Pharma
BBIO
$16.8B
$2.5M 0.12%
+150,000
New +$6.35M
PRPB
105
DELISTED
CC Neuberger Principal Holdings II Class A Ordinary Shares
PRPB
$2.48M 0.12%
250,000
RNW icon
106
ReNew
RNW
$2.22B
$2.13M 0.11%
273,300
-1,726,700
-86% -$15.2M
BBIO icon
107
BridgeBio Pharma
BBIO
$16.8B
$2.08M 0.1%
+125,000
New +$5.29M
PRPC
108
DELISTED
CC Neuberger Principal Holdings III
PRPC
$2.03M 0.1%
205,502
ATAI icon
109
AtaiBeckley Inc
ATAI
$2.66B
$1.97M 0.1%
258,080
CTAQ
110
DELISTED
Carney Technology Acquisition Corp. II Class A Common Stock
CTAQ
$1.95M 0.1%
200,000
KRNL
111
DELISTED
Kernel Group Holdings, Inc. Class A Ordinary Shares
KRNL
$1.95M 0.1%
200,000
AHRNU
112
DELISTED
Ahren Acquisition Corp Unit
AHRNU
$1.83M 0.09%
+183,010
New +$1.83M
NEUE
113
CALL
DELISTED
NeueHealth
NEUE
$1.72M 0.09%
+6,250
New +$2.89M
RVNC
114
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.63M 0.08%
+100,000
New +$1.67M
XOS icon
115
Xos
XOS
$28.3M
$1.57M 0.08%
16,667
SPAQ
116
DELISTED
Spartan Acquisition Corp. III
SPAQ
$1.57M 0.08%
158,639
AGCB
117
DELISTED
Altimeter Growth Corp 2
AGCB
$1.49M 0.07%
+151,400
New +$1.52M
BIOT
118
DELISTED
Biotech Acquisition Company Class A Ordinary Shares
BIOT
$1.48M 0.07%
+150,000
New +$1.47M
JWSM
119
DELISTED
Jaws Mustang Acquisition Corp.
JWSM
$1.46M 0.07%
150,000
BNAI
120
Brand Engagement Network
BNAI
$83.3M
$1.46M 0.07%
15,000
BSAQ
121
DELISTED
Black Spade Acquisition Co
BSAQ
$1.45M 0.07%
+150,000
New +$1.46M
MSPR
122
DELISTED
MSP Recovery Inc
MSPR
$1.37M 0.07%
31
FSRX
123
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
$1.32M 0.07%
+135,000
New +$1.32M
ASZ.WS
124
DELISTED
Austerlitz Acquisition Corporation II Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
ASZ.WS
$1.29M 0.06%
1,317,609
+1,007,521
+325% +$1.09M
FRGE
125
DELISTED
Forge Global Holdings
FRGE
$1.23M 0.06%
8,333

Similar funds

Antara Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Antara Capital held 297 positions worth $2.02B, up 55% from $1.31B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Antara Capital deployed $521M of net new capital in Q4 2021, opening 118 new positions and adding to 24 existing holdings. Its largest new stake was Hertz: 3,185,443 shares worth $148M.

By sector, the portfolio is most concentrated in Financials at 9.5% of assets, up from 8.3% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was ReNew, an estimated $15.2M trimmed.

  • Antara Capital's largest Q4 2021 buy was Hertz: 3,185,443 shares worth $148M.
  • Antara Capital added most to Austerlitz Acquisition Corporation II in Q4 2021, an estimated $29M increase.
  • Antara Capital's biggest Q4 2021 reduction was ReNew, cutting an estimated $15.2M.
  • Antara Capital fully exited SilverSPAC Inc. Unit in Q4 2021, selling an estimated $23.3M.
  • Antara Capital's ten largest holdings make up 44% of its $2.02B portfolio in Q4 2021.
  • Antara Capital opened 118 new positions and closed 65 in Q4 2021.
  • Antara Capital's portfolio value rose 55% quarter-over-quarter to $2.02B.

Based on Antara Capital's 13F filing for Q4 2021, filed 14 Feb 2022.